Flu vaccines updated for 2014/15 season

The influenza vaccine listings in MIMS have been updated for the 2014/15 season, including updated strains and two new tetravalent vaccines.

All people aged 65 years and older should receive an annual dose of the flu vaccine. | SCIENCE PHOTO LIBRARY
All people aged 65 years and older should receive an annual dose of the flu vaccine. | SCIENCE PHOTO LIBRARY

The trivalent vaccines available for this season are: Agrippal, Optaflu (Novartis), Enzira (Pfizer), Imuvac (Abbott Healthcare), Inactivated Influenza Vaccine BP and Intanza (Sanofi Pasteur MSD). 

New influenza B strain

In accordance with EMA/WHO guidelines for the 2014/15 season, the vaccines contain the following strains:

  • A/California/7/2009 as the H1N1-like component (as last season)
  • A/Texas/50/2012 as the H3N2-like component
  • B/Massachusetts/2/2012 as the influenza B component.

Two tetravalent vaccines

Two tetravalent vaccines are also available this year: Fluenz Tetra (AstraZeneca) and Fluarix Tetra (GSK), which contain the additional influenza B strain B/Brisbane/60/2008. Care must be taken not to confuse these vaccines as Fluenz Tetra is a live attenuated intranasal spray indicated for use only in children and adolescents, and Fluarix Tetra is an inactivated intramuscular preparation that is not approved for use in children under 3 years.

Childhood flu vaccine programme continues

Fluenz Tetra replaces Fluenz on the routine childhood vaccination schedule, which has been extended this year to include all children aged 2 to 4 years.

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases